Advagene Biopharma Co Ltd banner
A

Advagene Biopharma Co Ltd
TPEX:6709

Watchlist Manager
Advagene Biopharma Co Ltd
TPEX:6709
Watchlist
Price: 24.75 TWD 0.81% Market Closed
Market Cap: NT$1.7B

Dividends

Advagene Biopharma Co Ltd
does not pay dividends

Shareholder Yield

Current shareholder yield for Advagene Biopharma Co Ltd is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

Price
Advagene Biopharma Co Ltd

Annual Price Range
24.75
52w Low
23.15
52w High
37
Price Metrics
Average Annual Return -9.41%
Standard Deviation of Annual Returns 28.05%
Max Drawdown -72%
Shares Statistics
Market Capitalization 1.7B TWD
Shares Outstanding 69 380 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

Stock Splits

Advagene Biopharma Co Ltd's latest stock split occurred on Aug 2, 2023

The company executed a 3457-for-3426 stock split, meaning that for every 3426 shares held, investors received 3457 new shares.

Before the split, Advagene Biopharma Co Ltd traded at 28.5417 per share. Afterward, the share price was about 28.8.

The adjusted shares began trading on Aug 2, 2023. This was stock split number 2 in Advagene Biopharma Co Ltd's history, following the previous one in Sep 2, 2020.

Pre-Split Price
28.5417 28.5417
Post-Split Price
28.8
Before
After